Today is release day for a very special song from a incredibly special band composed of four talented teens all living with autoimmune Type 1 diabetes (T1D). This song, co-written by them aims to shed light on the challenges of living with T1D and raise awareness of the condition in response to a recent survey from Sanofi, of 200 UK adults living with T1D highlighting the significant impact of T1D on those living with the condition .

The original song is called “Rise Up” to empower young people living with T1D and help them feel less alone. They’re asking the UK and indeed the world, to get behind them and get them to Number One in the charts!

The band was brought together by Sanofi through a UK-wide audition process for kids taking part in Stagecoach Performing Arts, with Hampshire's Lola-Belle successfully winning her role in the band alongside three other performers. Also featured is Duke Al Durham, a UK spoken word poet and hip-hop artist also living with T1D. Together with Duke, the band have contributed their own lived experiences to the song's lyrics creating a meaningful anthem for those living with T1D. The song has been released on Spotify under the name 1Type and Sanofi will donate an amount matching the profits from song to charities that support people living with T1D.

undefined

1Type Band member & Stagecoach student

undefined

undefined

Chief Operating Officer, Stagecoach Performing Arts

undefined

T1D is an autoimmune, complex, and lifelong condition – and it can happen at any age even without family history. It can be a challenging disease with lifelong clinical, economic, and emotional unmet needs for patients and families. In the UK, there is a growing prevalence where approximately 400,000 people are living with the disease, including about 32,000 people 19 years of age and younger. It is known that T1D is not caused by diet or lifestyle and the causes of T1D are currently not fully understood. Researchers are exploring the genes and environmental triggers to understand if they play a part in causing the body’s immune system to malfunction and start attacking the insulin-producing beta cells in the pancreas. In the UK, T1D is managed through insulin therapy and glucose monitoring.

Research has expanded our understanding of the underlying autoimmune mechanisms of T1D and has now enabled earlier detection of the disease before symptoms appear.

undefined

General Manager, General Medicines UK and Ireland, Sanofi

undefined